vesanoid 10 mg soft capsules
cheplapharm arzneimittel gmbh - tretinoin - capsule, soft - 10 milligram(s) - cytostatic-differentiating agent
xenical
cheplapharm arzneimittel gmbh - orlistat - obesity - antiobesity preparations, excl. diet products - xenical is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (bmi) greater or equal to 30 kg/m2, or overweight patients (bmi > 28 kg/m2) with associated risk factors.treatment with orlistat should be discontinued after 12 weeks if patients have been unable to lose at least 5% of the body weight as measured at the start of therapy.
dilatrend tablets
cheplapharm arzneimittel gmbh - carvedilol - tablets - 6,25mg
dilatrend tablets
cheplapharm arzneimittel gmbh - carvedilol - tablets - 12,5mg
dilatrend tablets
cheplapharm arzneimittel gmbh - carvedilol - tablets - 25mg
anexate 500 micrograms/5ml, solution for injection or infusion
cheplapharm arzneimittel gmbh - flumazenil - solution for injection/infusion - 500 micrograms/5ml - antidotes; flumazenil
konakion mm ampoules 10 mg/ml solution for injection and oral solution
cheplapharm arzneimittel gmbh - phytomenadione - solution for injection - 10 milligram(s)/millilitre - vitamin k; phytomenadione
konakion mm paediatric ampoules 2 mg/ 0.2 ml oral solution or solution for injection
cheplapharm arzneimittel gmbh - phytomenadione - solution for injection - 2/0.2 milligram(s)/millilitre - vitamin k; phytomenadione
vepesid 100 mg capsule, soft
cheplapharm arzneimittel gmbh - etoposide - capsule, soft - 100 milligram(s) - podophyllotoxin derivatives; etoposide
vepesid 50 mg capsule, soft
cheplapharm arzneimittel gmbh - etoposide - capsule, soft - 50 milligram(s) - podophyllotoxin derivatives; etoposide